Eli Lilly’s experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant reductions in weight loss and blood sugar levels.
Source link
About The Author
Lilly’s Retatrutide Slashes Both Weight Loss and Blood Sugar Levels